Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction

Roberto F E Pedretti, Enrica Colombo, Simona Sarzi Braga, Luigi Ballardini, Bruno Carù

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objectives.: Our aims were 1) to assess whether oral pirenzepine could increase indexes of cardiac vagal activity in postinfarction patients, and 2) to compare the effects of this agent with those of transdermal scopolamine. Background.: Depression of vagal tone and reflexes predicts a poor arrhythmic outcome after myocardial infarction. Interventions for shifting the sympathovagal balance toward vagal dominance are now of increased clinical interest. Intravenous pirenzepine increases RR interval variability in normal volunteers, a finding that could have therapeutic implications if confirmed in postinfarction patients after oral administration of the drug. Methods.: In a single-blind placebo-controlled crossover trials, short-term RR interval variability and baroreceptor reflex sensitivity were evaluated in 20 patients an average of 19 ± 6 days after infarction. Analysis was performed during control conditions and during administration of placebo, oral pirenzepine and transdermal scopolamine. Results.: Compared with placebo, at a dose of 25 mg twice daily, pirenzepine significantly increased all time and frequency domain measures of RR interval variability and augmented baroreceptor reflex sensitivity by 60% (mean ± 1 SD 10.4 ± 5.9 vs. 6.5 ± 3.2 ms/mm Hg, p = 0.0007). Pirenzepine and scopolamine showed a similar vagomimetic effect, but the overall incidence of adverse effects was lower with pirenzepine (1 [5%] of 20 vs. 10 [50%] of 20). Conclusions.: In patients with a recent myocardial infarction, oral pirenzepine proved equal to transdermal scopolamine in significantly increasing indexes of cardiac vagal activity. These data suggest that oral pirenzepine may have a therapeutic potential for preventing malignant ventricular arrhythmias after infarction.

Original languageEnglish
Pages (from-to)915-921
Number of pages7
JournalJournal of the American College of Cardiology
Volume25
Issue number4
DOIs
Publication statusPublished - Mar 15 1995

Fingerprint

Pirenzepine
Baroreflex
Heart Rate
Myocardial Infarction
Scopolamine Hydrobromide
Placebos
Infarction
Oral Administration
Cross-Over Studies
Reflex
Cardiac Arrhythmias
Healthy Volunteers
Incidence
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Nursing(all)

Cite this

Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction. / Pedretti, Roberto F E; Colombo, Enrica; Sarzi Braga, Simona; Ballardini, Luigi; Carù, Bruno.

In: Journal of the American College of Cardiology, Vol. 25, No. 4, 15.03.1995, p. 915-921.

Research output: Contribution to journalArticle

@article{10dfb430ae5147c58732242ddd8c04db,
title = "Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction",
abstract = "Objectives.: Our aims were 1) to assess whether oral pirenzepine could increase indexes of cardiac vagal activity in postinfarction patients, and 2) to compare the effects of this agent with those of transdermal scopolamine. Background.: Depression of vagal tone and reflexes predicts a poor arrhythmic outcome after myocardial infarction. Interventions for shifting the sympathovagal balance toward vagal dominance are now of increased clinical interest. Intravenous pirenzepine increases RR interval variability in normal volunteers, a finding that could have therapeutic implications if confirmed in postinfarction patients after oral administration of the drug. Methods.: In a single-blind placebo-controlled crossover trials, short-term RR interval variability and baroreceptor reflex sensitivity were evaluated in 20 patients an average of 19 ± 6 days after infarction. Analysis was performed during control conditions and during administration of placebo, oral pirenzepine and transdermal scopolamine. Results.: Compared with placebo, at a dose of 25 mg twice daily, pirenzepine significantly increased all time and frequency domain measures of RR interval variability and augmented baroreceptor reflex sensitivity by 60{\%} (mean ± 1 SD 10.4 ± 5.9 vs. 6.5 ± 3.2 ms/mm Hg, p = 0.0007). Pirenzepine and scopolamine showed a similar vagomimetic effect, but the overall incidence of adverse effects was lower with pirenzepine (1 [5{\%}] of 20 vs. 10 [50{\%}] of 20). Conclusions.: In patients with a recent myocardial infarction, oral pirenzepine proved equal to transdermal scopolamine in significantly increasing indexes of cardiac vagal activity. These data suggest that oral pirenzepine may have a therapeutic potential for preventing malignant ventricular arrhythmias after infarction.",
author = "Pedretti, {Roberto F E} and Enrica Colombo and {Sarzi Braga}, Simona and Luigi Ballardini and Bruno Car{\`u}",
year = "1995",
month = "3",
day = "15",
doi = "10.1016/0735-1097(94)00468-6",
language = "English",
volume = "25",
pages = "915--921",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction

AU - Pedretti, Roberto F E

AU - Colombo, Enrica

AU - Sarzi Braga, Simona

AU - Ballardini, Luigi

AU - Carù, Bruno

PY - 1995/3/15

Y1 - 1995/3/15

N2 - Objectives.: Our aims were 1) to assess whether oral pirenzepine could increase indexes of cardiac vagal activity in postinfarction patients, and 2) to compare the effects of this agent with those of transdermal scopolamine. Background.: Depression of vagal tone and reflexes predicts a poor arrhythmic outcome after myocardial infarction. Interventions for shifting the sympathovagal balance toward vagal dominance are now of increased clinical interest. Intravenous pirenzepine increases RR interval variability in normal volunteers, a finding that could have therapeutic implications if confirmed in postinfarction patients after oral administration of the drug. Methods.: In a single-blind placebo-controlled crossover trials, short-term RR interval variability and baroreceptor reflex sensitivity were evaluated in 20 patients an average of 19 ± 6 days after infarction. Analysis was performed during control conditions and during administration of placebo, oral pirenzepine and transdermal scopolamine. Results.: Compared with placebo, at a dose of 25 mg twice daily, pirenzepine significantly increased all time and frequency domain measures of RR interval variability and augmented baroreceptor reflex sensitivity by 60% (mean ± 1 SD 10.4 ± 5.9 vs. 6.5 ± 3.2 ms/mm Hg, p = 0.0007). Pirenzepine and scopolamine showed a similar vagomimetic effect, but the overall incidence of adverse effects was lower with pirenzepine (1 [5%] of 20 vs. 10 [50%] of 20). Conclusions.: In patients with a recent myocardial infarction, oral pirenzepine proved equal to transdermal scopolamine in significantly increasing indexes of cardiac vagal activity. These data suggest that oral pirenzepine may have a therapeutic potential for preventing malignant ventricular arrhythmias after infarction.

AB - Objectives.: Our aims were 1) to assess whether oral pirenzepine could increase indexes of cardiac vagal activity in postinfarction patients, and 2) to compare the effects of this agent with those of transdermal scopolamine. Background.: Depression of vagal tone and reflexes predicts a poor arrhythmic outcome after myocardial infarction. Interventions for shifting the sympathovagal balance toward vagal dominance are now of increased clinical interest. Intravenous pirenzepine increases RR interval variability in normal volunteers, a finding that could have therapeutic implications if confirmed in postinfarction patients after oral administration of the drug. Methods.: In a single-blind placebo-controlled crossover trials, short-term RR interval variability and baroreceptor reflex sensitivity were evaluated in 20 patients an average of 19 ± 6 days after infarction. Analysis was performed during control conditions and during administration of placebo, oral pirenzepine and transdermal scopolamine. Results.: Compared with placebo, at a dose of 25 mg twice daily, pirenzepine significantly increased all time and frequency domain measures of RR interval variability and augmented baroreceptor reflex sensitivity by 60% (mean ± 1 SD 10.4 ± 5.9 vs. 6.5 ± 3.2 ms/mm Hg, p = 0.0007). Pirenzepine and scopolamine showed a similar vagomimetic effect, but the overall incidence of adverse effects was lower with pirenzepine (1 [5%] of 20 vs. 10 [50%] of 20). Conclusions.: In patients with a recent myocardial infarction, oral pirenzepine proved equal to transdermal scopolamine in significantly increasing indexes of cardiac vagal activity. These data suggest that oral pirenzepine may have a therapeutic potential for preventing malignant ventricular arrhythmias after infarction.

UR - http://www.scopus.com/inward/record.url?scp=0028987378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028987378&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(94)00468-6

DO - 10.1016/0735-1097(94)00468-6

M3 - Article

C2 - 7884097

AN - SCOPUS:0028987378

VL - 25

SP - 915

EP - 921

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 4

ER -